What is the appropriate acute management for a 5'3", 225‑lb female with chronic obstructive pulmonary disease and chronic heart failure (on hydralazine, isosorbide mononitrate, nebivolol) who presents with acute decompensated heart failure (hypotension, hypoxemia, elevated BNP), respiratory alkalosis, severe hypothyroidism (TSH >100 µIU/mL, low free T4), bilateral lower‑extremity edema, bibasilar infiltrates, and a possible left hip fracture after a fall?

Acute Management of Acute Decompensated Heart Failure with Severe Hypothyroidism and Hypotension

This patient requires immediate ICU/CCU admission for acute decompensated heart failure with hypotension (BP 104/54), severe hypothyroidism (TSH >100), and respiratory distress—prioritize cautious IV loop diuretics, oxygen therapy, BiPAP support with close blood pressure monitoring, and urgent thyroid hormone replacement while holding nebivolol due to decompensated heart failure. 1, 2

Immediate Triage and Monitoring

This patient meets high-risk criteria requiring ICU/CCU admission: persistent dyspnea (RR 26), hemodynamic instability (hypotension with BP 104/54), hypoxemia (SpO2 90%, PaO2 53.6 mmHg), and elevated BNP (1025) indicating acute decompensated heart failure 1. The combination of respiratory distress, JVD 8cm, bilateral lower extremity edema, bibasilar infiltrates, and pleural effusions confirms volume overload despite relative hypotension 3.

Critical monitoring parameters:

• Continuous SpO2 monitoring (currently 90% on room air) 1
• Frequent blood pressure checks (every 15-30 minutes initially given hypotension)
• Strict intake/output measurement
• Daily weights at same time
• Serial electrolytes, BUN, creatinine (current Cr 1.9) during IV diuretic therapy 3

Respiratory Support

Initiate BiPAP immediately given respiratory rate 26 breaths/min, SpO2 <90%, and respiratory alkalosis (pH 7.49, PCO2 27.6) 1. The 2016 ESC guidelines (Class IIa, Level B) recommend non-invasive positive pressure ventilation for patients with respiratory distress (RR >25, SpO2 <90%) to decrease respiratory distress and reduce mechanical intubation rates 1.

Critical caveat: Non-invasive positive pressure ventilation can reduce blood pressure—this patient's BP is already 104/54, requiring extremely close blood pressure monitoring during BiPAP use 1. If BP drops below 90 mmHg systolic or patient develops signs of hypoperfusion, BiPAP may need to be discontinued or settings adjusted.

Provide supplemental oxygen to maintain SpO2 >90% (currently at threshold) 1. Avoid hyperoxia in this COPD patient as it may worsen ventilation-perfusion mismatch and suppress ventilation 1.

Diuretic Therapy—Modified Approach for Hypotension

Start IV furosemide cautiously despite hypotension, as this patient has clear volume overload (JVD 8cm, bilateral edema, pulmonary edema on CXR, BNP 1025) 3, 1. She is currently on hydrochlorothiazide 25 mg daily.

Specific dosing: Begin with 40 mg IV furosemide (at least equivalent to her chronic oral thiazide dose, converted to loop diuretic equivalent) 1. The 2009 ACC/AHA guidelines (Class I, Level B) recommend starting IV loop diuretics in the emergency department without delay, as early intervention improves outcomes 3.

Monitor closely:

• Urine output hourly initially
• Blood pressure every 15-30 minutes
• Signs of hypoperfusion (mental status, urine output, lactate if available)
• If inadequate diuresis occurs, consider adding metolazone or spironolactone rather than aggressive loop diuretic escalation given hypotension 3, 1

Critical pitfall: Aggressive diuresis in hypotensive patients risks worsening hypoperfusion. This patient's hypotension likely reflects both volume overload (high filling pressures) and low cardiac output—diuresis should improve hemodynamics by reducing preload, but requires careful titration 3.

Medication Management—Critical Adjustments

Hold Nebivolol Immediately

Discontinue nebivolol (beta-blocker) given decompensated cardiac failure 2. The FDA label explicitly contraindicates nebivolol in decompensated cardiac failure 2. While the 2016 ESC guidelines note that pre-existing beta-blocker therapy should generally be continued if there is no hemodynamic instability 1, this patient has both decompensated failure AND hypotension (BP 104/54), meeting criteria for temporary discontinuation.

Hold or Reduce Vasodilators

Hold isosorbide mononitrate 60 mg daily temporarily given hypotension (BP 104/54) 4. Nitrates cause venodilatation and can worsen hypotension in volume-depleted or low-output states 4.

Consider holding hydralazine 50 mg TID temporarily given hypotension—this arterial vasodilator will further drop blood pressure.

Continue Other Medications

• Continue aspirin 81 mg, clopidogrel 75 mg (post-MI/stent)
• Continue rosuvastatin 40 mg
• Continue albuterol-ipratropium PRN for COPD (avoid overuse of beta-agonists in heart failure) 5, 6
• Hold fluticasone-vilanterol temporarily if patient requires frequent albuterol-ipratropium for acute symptoms

Severe Hypothyroidism—Urgent Treatment

TSH 112.7 with low free T4 0.56 represents severe hypothyroidism and is a critical precipitating factor for this acute decompensation 3. Hypothyroidism causes decreased cardiac contractility, increased systemic vascular resistance, and can precipitate heart failure exacerbations.

Immediate thyroid replacement:

• Start IV levothyroxine if patient cannot take PO reliably (given respiratory distress, potential for intubation)
• If PO tolerated, increase levothyroxine dose from current 175 mcg to 200-250 mcg daily with endocrine consultation
• Monitor for arrhythmias and worsening ischemia with thyroid replacement in this CAD patient
• Recheck TSH and free T4 in 1 week, then adjust

The severe hypothyroidism likely contributed to cognitive changes ("forgetfulness," unable to spell WORLD backward), weakness, and heart failure decompensation.

Additional Precipitating Factors to Address

Rule Out Acute Coronary Syndrome

Check troponin immediately given CAD history, though EKG shows only non-specific ST changes 3. ACS is a common precipitant requiring specific treatment 3.

Evaluate for Infection

WBC 11.5 with cough × 3 days—check chest X-ray for infiltrate (current CXR shows bibasilar airspace disease that may represent edema vs. infection), obtain blood cultures, consider empiric antibiotics if infection suspected as precipitant 3.

Hip Fracture Evaluation

Left hip pain after fall—obtain hip X-ray to rule out fracture. If fracture present, coordinate with orthopedics but optimize cardiac status first before surgery.

Medication/Dietary Non-compliance

Patient reports not working × 3 days, too tired for usual activities—assess for missed medications or dietary indiscretion as precipitants 3.

Avoid Inotropes Unless Cardiogenic Shock

Do not start dobutamine or other inotropes at this time 1, 7, 8. While BP is low (104/54), the patient does not have cardiogenic shock (adequate mentation initially, no evidence of end-organ hypoperfusion beyond mild creatinine elevation). The 2016 ESC guidelines reserve inotropes for patients with hypotension AND evidence of hypoperfusion/shock 1. Inotropes increase mortality due to arrhythmias and should be used only when absolutely necessary 8.

If BP drops below 90 mmHg systolic with signs of hypoperfusion (decreased urine output, worsening mental status, cold extremities, rising lactate), then consider:

• Fluid bolus 250 mL NS first to assess volume responsiveness 7
• If no response, start dobutamine 2.5-5 mcg/kg/min (lowest effective dose) 7, 8
• Avoid norepinephrine unless true cardiogenic shock develops

Transition Planning

Once stabilized (improved oxygenation, reduced congestion, stable BP):

• Transition from IV to oral diuretics when urine output adequate and symptoms improving 9
• Restart nebivolol at lower dose (e.g., 2.5 mg daily) once euvolemic and BP stable >100 systolic 5
• Restart isosorbide mononitrate at reduced dose once BP stable
• Optimize thyroid replacement to achieve euthyroid state
• Ensure patient receives pneumococcal vaccine (not yet received per history)
• Early follow-up within 7 days of discharge to reassess volume status, renal function, thyroid levels, and medication tolerance 9, 10

Key Pitfalls to Avoid

1. Do not withhold diuretics solely due to hypotension when clear volume overload exists—cautious diuresis often improves hemodynamics 3
2. Do not use BiPAP without close BP monitoring in hypotensive patients—can precipitate cardiovascular collapse 1
3. Do not continue beta-blockers in decompensated heart failure with hypotension—temporary discontinuation is appropriate despite general recommendation to continue 2, 5
4. Do not miss severe hypothyroidism as precipitant—requires urgent treatment 3
5. Do not start inotropes prematurely—reserve for true cardiogenic shock with hypoperfusion 1, 7, 8
6. Do not overlook COPD exacerbation component—may require steroids and antibiotics if infection present 10, 5